BCG unresponsive non-muscle invasive bladder ... Instill intravesically only after dilution. Total time from vial puncture to the completion of the intravesical instillation should not exceed ...
BCG unresponsive non-muscle invasive bladder cancer (NMIBC ... Instill intravesically only after dilution. Total time from vial puncture to the completion of the intravesical instillation should not ...
NMIBC BCG Unresponsive Papillary Disease ... Instill intravesically only after dilution. Total time from vial puncture to the completion of the intravesical instillation should not exceed 2 ...
Boston Consulting Group Related stories BCG had a global revenue of about $12 billion in 2023. BCG is led by Christoph Schweizer, who has served as CEO since 2021, and Rich Lesser, the Global ...
Researchers headed by a team at Pitt University, in collaboration with scientists at Cornell University, have developed a self-destructing, intravenous (i.v.) Bacillus Calmette-Guérin (BCG ...
Neonatologist Valentina Gerginova holds a dose of BCG vaccine in Vita private hospital in Sofia on May 20, 2012. A 2011 study said the New Orleans area has tuberculosis rates that are higher than ...
BCG unresponsive non-muscle invasive bladder cancer (NMIBC) in the papillary indication: Anticipated supplemental biologics license application (BLA) submission in 2025 Alternative source of BCG ...
[JONAH ONYANGO/STANDARD.] A nationwide shortage of Bacillus Calmette-Guerin (BCG) vaccines in the country leaves Kenyan newborns vulnerable to Tuberculosis (TB), a disease with a high prevalence ...
In its approved indication, Anktiva has produced outstanding data. There are 4-5 approved drugs or standards of care in BCG-unresponsive NMIBC, and neither complete responses nor their duration ...
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback